Latest Commercialisation News

4DS Memory Limited is set to acquire Australian Edge-AI software firm Jenesys, raising $5 million to integrate its autonomous systems capabilities with 4DS’s PCMO ReRAM technology, targeting computing-in-memory and neuromorphic markets.

Wide Open Agriculture cut its loss to $3.64 million in FY2026 as it pivots from owning manufacturing to a capital-light contract model, while securing global commercial traction for its lupin-based ingredients.

Hydrix is ramping up its defence technology efforts, focusing on sensing and autonomous systems aligned with Australia’s $425 billion 2026 National Defence Strategy. The company is developing internal prototypes and forging partnerships to commercialise intellectual property in counter-drone and ISR applications.

CurveBeam AI’s FY2026 results show a 28% revenue decline and a 12% increase in net loss, while advancing its China commercialisation and robotic surgery integration strategies. The company also announced a $6-7 million capital raise post-year-end.

Parkway Corporate has landed a $2 million contract to supply industrial-scale mine dewatering equipment to a top 10 global mining company, reinforcing its position in large-scale wastewater treatment solutions.

IperionX has landed a second U.S. Army task order worth US$11.5 million to expand its industrial-scale titanium manufacturing capacity in Virginia, advancing its integrated powder-to-part platform for defense applications.

xReality Group (ASX: XRG) delivered a standout FY26 with total income up 43% to $20 million and EBITDA surging to $3.8 million, backed by rapid expansion of its Operator XR defence training platform.

Lindian Resources has secured exclusive rights to over 13,000 tonnes of heavy rare earth feedstock in Kazakhstan, aiming to boost output at its wholly owned SARECO processing facility with dysprosium, terbium, and yttrium-rich material.

EMVision has accelerated recruitment in its pivotal emu™ brain scanner trial, surpassing 200 patients and advancing FDA discussions to broaden clinical endpoints, setting the stage for regulatory submission in early 2027.

Ceretas Limited posted a $1.63 million net loss for FY26 on $1.28 million revenue from government grants, advancing its clinical-stage Alzheimer’s ultrasound platform. The company completed an $8 million IPO in July to fund pivotal trials and device development.

BluGlass Limited reported a 5% reduction in its net loss to A$10.39 million for FY26 despite a 10% revenue dip, boosted by new US defence and industry contracts and a significant capital raise to fund growth.

Dreadnought Resources has lodged a mining lease application for its Yin Rare Earth deposits in WA, underpinning its Gifford Creek Critical Metals Project with a substantial 30 million tonne resource and strong metallurgical credentials.